Comments

Greenwich LifeSciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GLSINASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Greenwich LifeSciences (GLSI) Forecast

News Earnings Greenwich LifeSciences (GLSI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Greenwich LifeSciences Stock Price, Quotes and Forecasts | NASDAQ:GLSI | Benzinga

Explore Greenwich LifeSciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GLSI.

Open	$9.67
Close	-
Volume / Avg.	39.59K / 72.27K
Day Range	$9.50 - $10.61
52 Wk Range	8.06 - 18.75
Market Cap	$128.89M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	15.86%
Days to Cover	12.1

Recent News

Over $1M Bet On United Security Bancshares? Check Out These 3 Stocks Insiders Are Buying

Avi Kapoor

Insiders Buying Greenwich LifeSciences And 2 Other Stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Avi Kapoor

Why Greenwich Lifesciences (GLSI) Stock Is Skyrocketing

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.67
Close	-
Volume / Avg.	39.59K / 72.27K
Day Range	$9.50 - $10.61
52 Wk Range	8.06 - 18.75
Market Cap	$128.89M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	15.86%
Days to Cover	12.1

About Greenwich LifeSciences Inc

Sector

Health Care

Industry

Biotechnology

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clini...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Greenwich LifeSciences (GLSI) stock?

You can purchase shares of Greenwich LifeSciences (NASDAQ:GLSI) through any online brokerage.

View our list of the best stock brokerages

Who are Greenwich LifeSciences (GLSI) competitors?

Other companies in Greenwich LifeSciences’s space includes: Molecular Partners (NASDAQ:MOLN), 4D Molecular Therapeutics (NASDAQ:FDMT), Quoin Pharmaceuticals (NASDAQ:QNRX), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).

What is the forecast, or price target, for Greenwich LifeSciences (GLSI) stock?

Greenwich LifeSciences has a consensus price target of $39.00.

What is the current price for Greenwich LifeSciences (GLSI)?

The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $9.71 last updated May 19, 2025 at 12:31 PM EDT.

Does Greenwich LifeSciences (GLSI) pay a dividend?

There are no upcoming dividends for Greenwich LifeSciences.

When is Greenwich LifeSciences (NASDAQ:GLSI) reporting earnings?

Greenwich LifeSciences’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Greenwich LifeSciences (GLSI) going to split?

There is no upcoming split for Greenwich LifeSciences.

What sector and industry does Greenwich LifeSciences (GLSI) operate in?

Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.